Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -24.94%17 Gross Margin % is 75.44% as of Dec. 2025, which is 3% below its 10-year median of 77.54. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Basel Medical Group ranks better than 82.88% on this metric.
The historical rank and industry rank for Basel Medical Group's Gross Margin % or its related term are showing as below:
BMGL'
s Gross Margin % Range Over the Past 10 Years
Min: 75.72 Med: 77.54 Max: 79.56
Current: 75.72
During the past 4 years, the highestGross Margin % of Basel Medical Group was 79.56%. The lowest was 75.72%. And the median was 77.54%.
BMGL's Gross Margin % is ranked better than 82.88% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 39.96
vs BMGL: 75.72
Basel Medical Group had a gross margin of 75.44% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Basel Medical Group was 0.00% per year.
Basel Medical Group (NAS:BMGL) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Basel Medical Group had a gross margin of 75.44% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Basel Medical Group Gross Margin % Related Terms
Basel Medical Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMGL vs AMS, HLYK, BICX: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Basel Medical Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Basel Medical Group (BMGL) has a Gross Margin % of 75.44% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Basel Medical Group and its competitors. This is near median its historical median of 77.54. Over the past decade, Basel Medical Group's Gross Margin % has ranged from 75.72 to 79.56. According to the industry distribution chart, Basel Medical Group ranks #108 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 17.1%.
Is Basel Medical Group's Gross Margin % too high?
Basel Medical Group's current Gross Margin % of 75.44% is near median its 10-year median of 77.54. Over the past 10 years, this metric has ranged from a low of 75.72 to a high of 79.56. The Healthcare Providers & Services industry median Gross Margin % is 39.96. Basel Medical Group's value of 75.44% is 88.8% above this industry median. Based on the distribution chart, Basel Medical Group ranks #108 out of 631 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Gross Margin % compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #108 out of 631 companies for Gross Margin %. This places Basel Medical Group in the top 17% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 39.96. Basel Medical Group's value of 75.44% is 88.8% above this benchmark. Historically, Basel Medical Group's own Gross Margin % has ranged from 75.72 to 79.56 over the past decade. While the company's 10-year median is 77.54 vs. the industry median of 39.96, Basel Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 39.96, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current Gross Margin % of 75.44% is 88.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 39.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current Gross Margin % is 75.44%, which is near median its own 10-year median of 77.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Gross Margin % of 75.44%. The current Gross Margin % is 75.44%, which is near median its 10-year median of 77.54 and 88.8% above the Healthcare Providers & Services industry median of 39.96. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Gross Margin % is 75.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
